Andrew J. D'Silva insider trades
Open-market stock purchases and sales by Andrew J. D'Silva, Chief Business Officer at OptimizeRx Corp, from SEC Form 4 filings since Aug 21, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | OPRX OptimizeRx Corp | Sold (not open market) | $3.5K |
| Sep 1, 2026 | OPRX OptimizeRx Corp | Sold (not open market) | $11.3K |
| Aug 21, 2026 | OPRX OptimizeRx Corp | Sold (not open market) | $9.6K |
| Aug 20, 2026 | OPRX OptimizeRx Corp | Bought (not open market) | — |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Sold (not open market) | $9.5K |
| Dec 11, 2025 | OPRX OptimizeRx Corp | Sold (not open market) | $12.2K |
Companies traded
- OPRX OptimizeRx Corp: other filings, last Oct 1, 2026